Skip to content

Tumors of the Peripheral Nervous System

Prognostic Factors in Tumors of the Peripheral Nervous System

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05735548
Enrollment
100
Registered
2023-02-21
Start date
2021-07-01
Completion date
2024-06-30
Last updated
2023-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor of Peripheral Nerve

Keywords

outcome, neurosurgery

Brief summary

The goal of this observational study is to individuate tumors' and patients' features influencing the outcome after surgical tumor removal.

Detailed description

Patients operated because of removal of Peripheral Nervous System (PNS) tumor will be recruited accordingly to the inclusion criteria: the aims of the study will be illustrated and the informed consent signed. All the clinical and neuroradiological perioperative documents of the enrolled patients will be analyzed. As follow-up, thorough neurological exam wil be performed and specific surveys about after surgery social and working life will be administered; neuroradiological imaging will be performed. Then, the results will be investigated to individuate which factors were related to the outcome.

Interventions

None listed

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 y.o. * neurosurgical removal of peripheral nerve tumor at our University Hospital Fondazione Policlinico Universitario Agostino Gemelli (FPG) during the previous 10 years * signed consent to study participation

Exclusion criteria

* \< 18 y.o. * neurosurgical treatment because other causes (chronic entrapment syndromes, acute nerve lesion) * denied consent to study participation

Design outcomes

Primary

MeasureTime frameDescription
functional outcomethrough study completion, an average of 3 yearsevaluation of: 1) Motor function accordingly to the Medical Research Council muscle power scale (MRC); 2) Sensation accordingly to The Ten Test for Sensation (TTTS); 3) Pain accordingly to the Numerical Rating Scale for Pain (NRS).
oncological outcomethrough study completion, an average of 3 yearsnumber of patients with tumor relapses

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026